We are live on ! Find out more
BIOA

BioAmber Inc.
BIOA

Delisted

BIOA was delisted on the 8th of February, 2018.

Back to rankings

15 hedge funds and large institutions have $27.3M invested in BioAmber Inc. in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

17% less funds holding

Funds holding: 18 → 15 (-3)

27% less capital invested

Capital invested by funds: $37.4M → $27.3M (-$10.2M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
15
Holders Change
-3
Holders Change %
-16.67%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
6
Reduced
4
Closed
3
Calls
$791K
Puts
–
Net Calls
+$791K
Net Calls Change
-$249K

Top Buyers

Rank Fund Capital Flow
1
PRCM
Pine River Capital Management
Minnesota
+$1.72M
2
WRF
Waddell & Reed Financial
Kansas
+$1.28M
3
CS
Credit Suisse
Switzerland
+$240K
4
LCS
Levin Capital Strategies
New York
+$56.9K
5
TRCT
Tower Research Capital (TRC)
New York
+$5.34K

Top Sellers

Rank Fund Capital Flow
1
MCM
Moore Capital Management
New York
-$2.06M
2
JGC
J. Goldman & Co
New York
-$863K
3
UOC
UBS O'Connor
Illinois
-$363K
4
Millennium Management
Millennium Management
New York
-$68.3K
5
Goldman Sachs
Goldman Sachs
New York
-$38.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$14.8M +$1.28M +225,507 +8%
PRCM
2
Pine River Capital Management
Minnesota
$4.12M +$1.72M +302,651 +56%
ACPU
3
Arrowgrass Capital Partners (US)
Delaware
$3.7M +$2.85K +500 +0.1%
CS
4
Credit Suisse
Switzerland
$1.21M +$240K +42,191 +21%
LCS
5
Levin Capital Strategies
New York
$857K +$56.9K +10,000 +6%
Alyeska Investment Group
6
Alyeska Investment Group
Illinois
$711K – – –
SCM
7
Saba Capital Management
New York
$625K – – –
Millennium Management
8
Millennium Management
New York
$603K -$68.3K -12,000 -9%
Deutsche Bank
9
Deutsche Bank
Germany
$220K – – –
UOC
10
UBS O'Connor
Illinois
$177K -$363K -63,832 -64%
NIMI
11
Natixis Investment Managers International
France
$157K – – –
Goldman Sachs
12
Goldman Sachs
New York
$81K -$38.1K -6,700 -29%
TRCT
13
Tower Research Capital (TRC)
New York
$13K +$5.34K +938 +55%
BIT
14
BlackRock Institutional Trust
California
$3K – – –
MCM
15
Moore Capital Management
New York
– -$2.06M -302,500 Closed
JGC
16
J. Goldman & Co
New York
– -$863K -126,900 Closed
Barclays
17
Barclays
United Kingdom
– -$7.47K -1,312 -98%
U
18
UBS
Switzerland
– -$3K -442 Closed

BIOA Hedge Fund Activity: Q3 2013 in Review

15 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q3 2013, worth a combined $27.3M — down 27% from $37.4M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BIOA and 0 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 6 added.

The largest buyer was Pine River Capital Management, adding an estimated $1.72M. The largest seller was Moore Capital Management, exiting entirely with an estimated $2.06M sold.

  • 15 institutional investors held BioAmber Inc. (BIOA) as of Q3 2013, down from 18 in Q2 2013.
  • Funds reported $27.3M of BioAmber Inc. stock for Q3 2013, down 27% quarter-over-quarter.
  • 0 funds opened new BioAmber Inc. positions in Q3 2013 and 3 closed out, a net change of -3 holders.
  • The largest BioAmber Inc. buyer in Q3 2013 was Pine River Capital Management, an estimated $1.72M added.
  • The largest BioAmber Inc. seller in Q3 2013 was Moore Capital Management, an estimated $2.06M sold.

Based on aggregated 13F filings for Q3 2013.